Aprogen Medicines Balance Sheet Health
Financial Health criteria checks 3/6
Aprogen Medicines has a total shareholder equity of ₩443.3B and total debt of ₩112.9B, which brings its debt-to-equity ratio to 25.5%. Its total assets and total liabilities are ₩619.9B and ₩176.6B respectively.
Key information
25.5%
Debt to equity ratio
₩112.87b
Debt
| Interest coverage ratio | n/a |
| Cash | ₩49.70b |
| Equity | ₩443.27b |
| Total liabilities | ₩176.63b |
| Total assets | ₩619.90b |
Recent financial health updates
Is Aprogen Medicines (KRX:007460) Using Too Much Debt?
Aug 22
Is Aprogen Medicines (KRX:007460) A Risky Investment?
May 21Recent updates
Aprogen Medicines Inc. (KRX:007460) May Have Run Too Fast Too Soon With Recent 25% Price Plummet
Sep 29Is Aprogen Medicines (KRX:007460) Using Too Much Debt?
Aug 22Aprogen Medicines Inc. (KRX:007460) Stock Rockets 41% As Investors Are Less Pessimistic Than Expected
Jul 21Aprogen Medicines Inc.'s (KRX:007460) 25% Share Price Plunge Could Signal Some Risk
May 31Is Aprogen Medicines (KRX:007460) A Risky Investment?
May 21Aprogen Medicines Inc. (KRX:007460) Investors Are Less Pessimistic Than Expected
Feb 26If You Had Bought Aprogen KIC's (KRX:007460) Shares Three Years Ago You Would Be Down 86%
Jan 07Financial Position Analysis
Short Term Liabilities: A007460's short term assets (₩162.4B) exceed its short term liabilities (₩119.3B).
Long Term Liabilities: A007460's short term assets (₩162.4B) exceed its long term liabilities (₩57.3B).
Debt to Equity History and Analysis
Debt Level: A007460's net debt to equity ratio (14.3%) is considered satisfactory.
Reducing Debt: A007460's debt to equity ratio has increased from 16.3% to 25.5% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: A007460 has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: A007460 has less than a year of cash runway if free cash flow continues to reduce at historical rates of 42.1% each year